Dr. Marc Schwartz, MD

Dr. Schwartz practices at NYU Langone - Tisch Hospital in New York, New York.

Dr. Schwartz's NPI, 1518385467, was assigned on March 28, 2014. Dr. Schwartz graduated from State University of New York at Stony Brook, School of Medicine in 2014. Dr. Schwartz holds Colorado license DR.0065072.

Dr. Schwartz's primary practice is NYU Langone - Tisch Hospital, at 550 1st Ave, New York, NY 10016 in New York County. The practice phone is (212) 263-1481.

Dr. Schwartz's primary practice is NYU Langone - Tisch Hospital in New York, New York. Dr. Schwartz is also affiliated with Tisch Hospital. The medical group on file is NYU Langone Orthopedic Surgery Associates. Dmand AI also links Dr. Schwartz to 2 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schwartz practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Schwartz's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Schwartz is licensed in Colorado.

CMS data shows 330 Medicare services from Dr. Schwartz across 4 procedure codes in 2024, for 79 Medicare patients. Medicare paid $31,046 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 79 Medicare patients who saw Dr. Schwartz in 2024. The largest group is 65 to 74, with 46 patients. 63% of them have high blood pressure, and 58% have high cholesterol. 20% are also on Medicaid. Their average risk score is 3.36, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Schwartz's median patient age at 68, with 43% women.

In 2024, Dr. Schwartz wrote 463 Medicare Part D claims for 58 patients. 65% of them were for generic drugs. CMS names the drug for 305 of them, across 11 drugs with 11 or more claims each, at $1,616,472 in total drug cost. In 2023, CMS named 184 claims across 7 drugs.

Dr. Schwartz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Schwartz as offering telehealth.

Dmand AI links 61 papers to Dr. Schwartz, published from 2010 to 2025. 2024 was the busiest year, with 10. The most frequent topics are Neuroma, Acoustic, Botulinum Toxins, Type A and Cranial Fossa, Middle. Dr. Schwartz has published most often in Otol Neurotol. Dr. Schwartz's most frequent co-authors are Marc Stuart Schwartz, MD, Rick Adam Friedman, MD, PhD and Omid Moshtaghi, MD.

Dmand AI links Dr. Schwartz to 1 clinical trial. 1 is still active or recruiting.

CMS Open Payments shows 9 general payments to Dr. Schwartz from 6 drug and device companies from 2018 to 2025. Consulting fees make up the largest share, 99% of the total. Abbvie Inc. paid the most, $14,671.

Dr. Schwartz graduated from State University of New York at Stony Brook, School of Medicine in 2014.